Molecular targets and anti-cancer potential of escin

QR Code

Molecular targets and anti-cancer potential of escin

Escin is a mixture of triterpenoid saponins extracted from the horse chestnut tree, Aesculus hippocastanum. Its potent anti-inflammatory and anti-odematous properties makes it a choice of therapy against chronic venous insufficiency and odema. More recently, escin is being actively investigated for...

Full description

Bibliographic Details
Main Authors:	Cheong, D., Arfuso, Frank, Sethi, G., Wang, L., Hui, K., Kumar, Alan Prem, Tran, T.
Format:	Journal Article
Published:	Elsevier 2018
Online Access:	http://hdl.handle.net/20.500.11937/67339

Similar Items

Endothelia-targeting protection by Escin in decompression sickness rats
by: Zhang, K., et al.
Published: (2017)

Potential anti-inflammatory and anti-cancer properties of farnesol
by: Jung, Y., et al.
Published: (2018)

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
by: Shanmugam, M., et al.
Published: (2017)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies
by: Shanmugam, M., et al.
Published: (2013)

The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
by: Arora, L., et al.
Published: (2018)

Role of RNF20 in cancer development and progression – a comprehensive review
by: Sethi, G., et al.
Published: (2018)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
by: Banik, K., et al.
Published: (2018)

Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
by: Shanmugam, M., et al.
Published: (2012)

Molecular targets modulated by fangchinoline in tumor cells and preclinical models
by: Mérarchi, M., et al.
Published: (2018)

Potential role of genipin in cancer therapy
by: Shanmugam, M., et al.
Published: (2018)

Thymoquinone: Potential cure for inflammatory disorders and cancer
by: Woo, C., et al.
Published: (2012)

Targeting transcription factor STAT3 for cancer prevention and therapy.
by: Chai, E., et al.
Published: (2015)

Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical review
by: Sethi, G., et al.
Published: (2018)

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
by: Dai, X., et al.
Published: (2015)

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)

Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
by: Shrimali, D., et al.
Published: (2013)

The role of resveratrol in cancer therapy
by: Ko, J., et al.
Published: (2017)

The potential role of boswellic acids in cancer prevention and treatment
by: Roy, N., et al.
Published: (2016)

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
by: Manu, K., et al.
Published: (2018)

Possible use of Punica granatum (Pomegranate) in cancer therapy
by: Khwairakpam, A., et al.
Published: (2018)

NF-κB in cancer therapy
by: Li, F., et al.
Published: (2015)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
by: Siveen, K., et al.
Published: (2013)

Antioxidant response elements: Discovery, classes, regulation and potential applications
by: Raghunath, A., et al.
Published: (2018)

SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma
by: Sethi, G., et al.
Published: (2017)

Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

In vitro assay for investigating potential anti-cancer agents targeting at metastatic level
by: Hashim, Yumi Zuhanis Has-Yun, et al.
Published: (2011)

Multifaceted link between cancer and inflammation
by: Sethi, G., et al.
Published: (2012)

PPARγ disease gene network and identification of therapeutic targets for prostate cancer
by: Venkatachalam, G., et al.
Published: (2011)

Novel tumor necrosis factor-a induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression
by: Padmavathi, G., et al.
Published: (2018)

Synthesis and characterization of ZnO–TiO2–chitosan–escin metallic nanocomposites: Evaluation of their antimicrobial and anticancer activities
by: Elderdery, Abozer Y., et al.
Published: (2022)

Pharmacological utilization of bergamottin, derived from grapefruits, in cancer prevention and therapy
by: Ko, J., et al.
Published: (2018)

Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356
by: Shanmugam, M., et al.
Published: (2018)

NHE-1: A promising target for novel anti-cancer therapeutics
by: Loo, S., et al.
Published: (2012)

Molecular targets of colorectal cancer: an insight on intracellular cellular signaling pathways
by: Pandurangan, Ashok Kumar, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0of6iqfht9t5q98rje9vcrrksr